Global Oral Proteins & Peptides Market Research Report (2021 to 2026) - by Drug Type and Region
10 sept. 2021 07h53 HE
|
Research and Markets
Dublin, Sept. 10, 2021 (GLOBE NEWSWIRE) -- The "Oral Proteins & Peptides Market Research Report by Drug Type, by Region - Global Forecast to 2026 - Cumulative Impact of COVID-19" report has been...
Lexaria Bioscience Corp. (NASDAQ: LEXX) on Forefront of Exciting Hypertension Innovation
06 août 2021 08h30 HE
|
Lexaria Bioscience Corp.
NEW YORK, Aug. 06, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Cardiovascular Disease Drug Market Offers...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Leads the Way in Innovating Hypertension Treatment
04 août 2021 08h30 HE
|
Lexaria Bioscience Corp.
NEW YORK, Aug. 04, 2021 (GLOBE NEWSWIRE) -- via InvestorWire — Lexaria Bioscience Corp. (NASDAQ: LEXX) today announces its placement in an editorial published by NetworkNewsWire ("NNW"), one of 50+...
Mountain Valley MD Appoints Chief Medical Officer
03 août 2021 08h45 HE
|
Mountain Valley MD Holdings Inc.
TORONTO, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Mountain Valley MD Holdings Inc. (the “Company” or “MVMD”) (CSE: MVMD) (FRA:20MP) (OTCQB: MVMDF) is pleased to announce the appointment of Dr. Azhar Rana...
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast Featuring Mark Palumbo, Founder & CEO of CannAssist International Corp.
17 févr. 2021 08h17 HE
|
InvestorBrandNetwork (IBN)
LOS ANGELES, Feb. 17, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- InvestorBrandNetwork (“IBN”), a multifaceted communications organization engaged in connecting public companies to the investment...
Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Featured in NetworkNewsAudio Publication Discussing Innovative Drug-Delivery Discovery
06 sept. 2019 08h30 HE
|
Lexaria Bioscience Corp.
NEW YORK, Sept. 06, 2019 (GLOBE NEWSWIRE) -- via NetworkNewsAudio – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) announces the availability of a NetworkNewsAudio publication titled, “Innovative...
Lexaria Bioscience Corp. Featured in CannabisNewsWire Publication Discussing Disruptive Potential of CBD Delivery Technology
30 mai 2019 08h35 HE
|
Lexaria Bioscience Corp.
NEW YORK, May 30, 2019 (GLOBE NEWSWIRE) -- via CannabisNewsWire – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today announces its placement in an editorial published by CannabisNewsWire...
Receptor Holdings Adds Alex Casdin to Board of Directors
08 avr. 2019 08h50 HE
|
Receptor Holding
SEATTLE, April 08, 2019 (GLOBE NEWSWIRE) -- Alexander W. Casdin, Founder, CEO, and Portfolio Manager of Reneo Capital Management LP, has been named to the Board of Directors of Receptor Holdings...
Plandai Biotechnology Exploring Opportunities in the U.S. Poultry Market
03 juil. 2018 08h00 HE
|
Plandai Biotechnology, Inc.
SORBEO™ Proprietary PREMIX Addresses Needs in the $65 Billion Industry LONDON, UNITED KINGDOM , July 03, 2018 (GLOBE NEWSWIRE) -- Plandai Biotechnology Inc. (OTC Markets: PLPL) (the “Company” or...
CORRECTING and REPLACING – Canntab Brings Pharma Standards to Medical Cannabis -- CFN Media
01 juin 2018 18h21 HE
|
CFN Media
SEATTLE, June 01, 2018 (GLOBE NEWSWIRE) -- In a release issued yesterday under the same headline by CFN Media, please be advised that a quote has been removed from the first paragraph....